These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12413427)

  • 21. Development of a hammerhead ribozyme against bcl-2. I. Preliminary evaluation of a potential gene therapeutic agent for hormone-refractory human prostate cancer.
    Dorai T; Olsson CA; Katz AE; Buttyan R
    Prostate; 1997 Sep; 32(4):246-58. PubMed ID: 9288183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ribozymes as therapeutic tools for genetic disease.
    Phylactou LA; Kilpatrick MW; Wood MJ
    Hum Mol Genet; 1998; 7(10):1649-53. PubMed ID: 9735387
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Construction of adenovirus for high level expression of small RNAs in mammalian cells. Application to a Bcl-2 ribozyme.
    Potter PM; McKenzie PP; Hussain N; Noonberg S; Morton CL; Harris LC
    Mol Biotechnol; 2000 Jun; 15(2):105-14. PubMed ID: 10949823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hammerhead ribozymes as therapeutic agents for bladder cancer.
    Irie A; Kashani-Sabet M; Scanlon KJ; Uchida T; Baba S
    Mol Urol; 2000; 4(2):61-6. PubMed ID: 12006244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional characterization of ribozymes expressed using U1 and T7 vectors for the intracellular cleavage of ANF mRNA.
    De Young MB; Kincade-Denker J; Boehm CA; Riek RP; Mamone JA; McSwiggen JA; Graham RM
    Biochemistry; 1994 Oct; 33(40):12127-38. PubMed ID: 7918434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and anti-HIV-1 activity of hammerhead and hairpin ribozymes containing a stable loop.
    Koizumi M; Ozawa Y; Yagi R; Nishigaki T; Kaneko M; Oka S; Kimura S; Iwamoto A; Komatsu Y; Ohtsuka E
    Nucleosides Nucleotides; 1998; 17(1-3):207-18. PubMed ID: 9708348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The application of ribozymes to HIV infection.
    Rossi JJ
    Curr Opin Mol Ther; 1999 Jun; 1(3):316-22. PubMed ID: 11713796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthetic hammerhead ribozymes as tools in gene expression.
    Lyngstadaas SP
    Crit Rev Oral Biol Med; 2001; 12(6):469-78. PubMed ID: 11806517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and expression of chimeric U1/ribozyme transgenes.
    Abounader R; Montgomery R; Dietz H; Laterra J
    Methods Mol Biol; 2004; 252():209-19. PubMed ID: 15017051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retrozymes are a unique family of non-autonomous retrotransposons with hammerhead ribozymes that propagate in plants through circular RNAs.
    Cervera A; Urbina D; de la Peña M
    Genome Biol; 2016 Jun; 17(1):135. PubMed ID: 27339130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ribozymes: from mechanistic studies to applications in vivo.
    Ohkawa J; Koguma T; Kohda T; Taira K
    J Biochem; 1995 Aug; 118(2):251-8. PubMed ID: 8543555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ribozymes in the age of molecular therapeutics.
    Bagheri S; Kashani-Sabet M
    Curr Mol Med; 2004 Aug; 4(5):489-506. PubMed ID: 15267221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel approach to glioma gene therapy: down-regulation of the vascular endothelial growth factor in glioma cells using ribozymes.
    Ke LD; Fueyo J; Chen X; Steck PA; Shi YX; Im SA; Yung WK
    Int J Oncol; 1998 Jun; 12(6):1391-6. PubMed ID: 9592205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Catalytic activity and stability of hammerhead ribozymes containing 2'-acetamido-2'-deoxyribonucleosides.
    Hendrix C; Mahieu M; Anné J; Van Calenbergh S; Van Aerschot A; Content J; Herdewijn P
    Biochem Biophys Res Commun; 1995 May; 210(1):67-73. PubMed ID: 7741750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of c-Ha-ras gene expression by hammerhead ribozymes containing a stable C(UUCG)G hairpin loop.
    Koizumi M; Kamiya H; Ohtsuka E
    Biol Pharm Bull; 1993 Sep; 16(9):879-83. PubMed ID: 8268855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ribozymes.
    Steinecke P; Schreier PH
    Methods Cell Biol; 1995; 50():449-60. PubMed ID: 8531816
    [No Abstract]   [Full Text] [Related]  

  • 37. A computational approach to predict suitable target sites for trans-acting minimal hammerhead ribozymes.
    Mercatanti A; Lande C; Citti L
    Methods Mol Biol; 2012; 848():337-56. PubMed ID: 22315079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A self-processing ribozyme cassette: utility against human papillomavirus 11 E6/E7 mRNA and hepatitis B virus.
    Pan WH; Xin P; Morrey JD; Clawson GA
    Mol Ther; 2004 Apr; 9(4):596-606. PubMed ID: 15093190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism of action of hammerhead ribozymes and their applications in vivo: rapid identification of functional genes in the post-genome era by novel hybrid ribozyme libraries.
    Takagi Y; Suyama E; Kawasaki H; Miyagishi M; Taira K
    Biochem Soc Trans; 2002 Nov; 30(Pt 6):1145-9. PubMed ID: 12440992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ribozyme gene therapy for autosomal dominant retinal disease.
    Hauswirth WW; LaVail MM; Flannery JG; Lewin AS
    Clin Chem Lab Med; 2000 Feb; 38(2):147-53. PubMed ID: 10834402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.